Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque. However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles. Here we show that a decline in the autophagy–lysosome system contributes to this as evidenced by a derangement in key autophagy markers in both mouse and human atherosclerotic plaques. By augmenting macrophage TFEB, the master transcriptional regulator of autophagy–lysosomal biogenesis, we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggregates and blunt macrophage apoptosis and pro-inflammatory IL-1β levels, leading to reduced atherosclerosis. In order to harness this degradative response therapeutically, we also describe a natural sugar called trehalose as an inducer of macrophage autophagy–lysosomal biogenesis and show trehalose’s ability to recapitulate the atheroprotective properties of macrophage TFEB overexpression. Our data support this practical method of enhancing the degradative capacity of macrophages as a therapy for atherosclerotic vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Atherosclerosis | Macrophage‐specific overexpression of Tfeb | Reduced development of atherogenic plaque after stimulation of lysosomal biogenesis in macrophages | Sergin et al (2017) |”
From Autophagy in major human diseases (2021) · cites this paper as Sergin et al (2017)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Almendinger, J., Oberst, A., Ness, R., Dillon, C. P., Fitzgerald, P., Hengartner, M. O., & Green, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113421108 · Cited by 655
RetractedA SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 2×
“In addition, dual TFEB-TG/ ATG5-KO macrophages subjected to atherogenic lipids were no longer able to (1) reduce the number of p62-enriched protein aggregates or (2) blunt the degree of apoptosis (Fig.”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Self-citationA Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Self-citationNew insights on trehalose: a multifunctional molecule
Elbein, A. D. (2003) · Glycobiology · doi:10.1093/glycob/cwg047 · Cited by 1,954
Cited by
Items 201–300 of 364
Jackson, A. O., Rahman, G. A., & Long, S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-04037-6 · Cited by 16
“Furthermore, chemokine receptor type 7 and induced nitric oxide synthase (iNOS) production macrophage increased inflammation, adhesion molecules expression and immune cell recruitment causing vascular remodeling [32].”
BackgroundWei, J., Huang, L., Li, D., He, J., Li, Y., He, F., Fang, W., & Wei, G. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100308 · Cited by 17
Yuan, S., Zhang, Z., & Li, Z.-L. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00402 · Cited by 15
“Trehalose also enhances the degradative capacity of macrophages and is considered as a therapy for atherosclerotic vascular disease (Sergin et al., 2017).”
BackgroundSun, Y., Gao, W. Z., Liu, Z., Yang, H., Cao, W., Tong, L., & Tang, B. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01398 · Cited by 17
Huo, D., Jiang, X., Wu, X., Ren, C., Yu, Z., Liu, J., Li, H., Ruan, Y., Wen, J., Chen, T., et al. (2018) · Gene · doi:10.1016/j.gene.2018.04.085 · Cited by 15
Li, F., Wang, Y., Chen, S., Liu, J., Wu, X., Maimati, Y., Ding, F., Wang, X. Q., Shen, Y., Chen, Q., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf241 · Cited by 17
James, A., Hendrixson, J. A., Kadhim, I., Marques-Carvalho, A., Laster, J., Crawford, J., Thostenson, J., Wanchai, V., Sato, A. Y., Nookaew, I., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.191688 · Cited by 20
“This approach is based on evidence that targeted overexpression of Tfeb in myotubes (13), neurons (14–16), oligodendrocytes (15), macrophages (17), cardiac myocytes (18), or chondrocytes (19) is sufficient to induce autophagy and alleviate dysfunction in murine models of Pompe disease, Parkinson…”
Transcription factor EB as a key molecular factor in human health and its implication in diseases
Gebrie, A. (2023) · SAGE Open Medicine · doi:10.1177/20503121231157209 · Cited by 14
Trehalose enhances macrophage autophagy to promote myelin debris clearance after spinal cord injury
Ma, Z., Meng, C., Wang, X., Zhao, Y., Wang, J., Chen, Y., Li, Y., Jiang, Y., Ouyang, F., Li, J., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01357-2 · Cited by 15
“We thus investigated the trehalose’s effect on myelin debris clearance by macrophages after SCI. Trehalose (3 g/ kg/ day) [20] was injected intraperitoneally starting 4 h after SCI until day 14.”
InfluentialOtoda, T., Aihara, K., & Takayama, T. (2025) · Biomedicines · doi:10.3390/biomedicines13051053 · Cited by 14
“However, specific lysosome-targeted compounds, including TFEB activators (e.g., trehalose [78] and curcumin [85]) and TRPML1 agonists, require further clinical validation [76].”
Milewska, M., & Wandzik, I. (2019) · Polymers · doi:10.3390/polym11122027 · Cited by 17
“In the first study trehalose’s ability to induce macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis has been the groundwork [12].”
Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target
Wang, Z., Li, X., Moura, A. K., Hu, J. Z., Wang, Y., & Zhang, Y. (2025) · Cells · doi:10.3390/cells14030183 · Cited by 18
Quach, C., Helou, D. G., Li, M., Hurrell, B. P., Howard, E. D., Shafiei-Jahani, P., Soroosh, P., Ou, J. J., Razani, B., Rehan, V. K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112990 · Cited by 15
Self-citationTrehalose promotes atherosclerosis regression in female mice
Robichaud, S., Rochon, V., Emerton, C., Laval, T., & Ouimet, M. I. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1298014 · Cited by 16
Liu, J., Wang, X., Yu, J., Fu, J., Zhang, Q., Pang, J., Pang, J., & Chen, Y. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135942 · Cited by 13
Guo, B., Shi, X., Jiang, Q., Pan, Y., Yang, Y., Liu, Y., Chen, S., Zhu, W., Ren, L., Liang, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202405318 · Cited by 18
Fang, X., Zhuang, X., Zheng, L., Lv, Y., Gao, F., Mo, C., & Zheng, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123330 · Cited by 14
Targeting fatty acid synthase reduces aortic atherosclerosis and inflammation
Meade, R., Ibrahim, D., Engel, C., Belaygorod, L., Arif, B., Hsu, F., Adak, S., Catlett, R., Zhou, M., Ilagan, M. X. G., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07656-1 · Cited by 16
Self-citationTargeting hepatocyte carbohydrate transport to mimic fasting and calorie restriction
Kading, J. C., Finck, B. N., & DeBosch, B. J. (2020) · FEBS Journal · doi:10.1111/febs.15482 · Cited by 13
Trehalose-releasing nanogels: A step toward a trehalose delivery vehicle for autophagy stimulation
Maruf, A., Milewska, M., Kovács, T., Varga, M., Vellai, T., Lalik, A., Student, S., Borges, O., & Wandzik, I. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212969 · Cited by 15
Wang, G., Jing, S.-Y., Liu, G., Guo, X., Zhao, W., Jia, X.-L., Zheng, M., & Tan, W. (2022) · Disease Markers · doi:10.1155/2022/7172583 · Cited by 17
“Recently, numerous studies have proved that macrophage autophagy played an important role in the development of AS, that is, macrophages are the key catabolic workhorse specialized in clearing lipid and dead cell debris in the atherosclerotic plaque [16, 54, 55].”
BackgroundZahedi, S. N., Pourajam, S., Zaker, E., Kouhpayeh, S., Mirbod, S. M., Tavangar, M., Boshtam, M., Kahkesh, K. H., Qian, Q., Zhang, F., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115674 · Cited by 15
Sakai, M., Ohnishi, K., Masuda, M., Ohminami, H., Yamanaka‐Okumura, H., Hara, T., & Taketani, Y. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1727309 · Cited by 13
“tion, suppressed the development of aortic root atherosclerosis in apolipoprotein E (ApoE)-knockout mice [10].”
BackgroundSrsf3-Dependent APA Drives Macrophage Maturation and Limits Atherosclerosis
Yang, X., Zhang, X., Tian, Y., Yang, J., Jia, Y., Xie, Y., Cheng, L., Chen, S., Wu, L., Qin, Y., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.326111 · Cited by 14
“8 Moreover, microRNA-mediated posttranscriptional regulation of gene expression is deeply involved in macrophage activation, phagocytosis, and cell death during atherosclerosis initiation and progression.”
Self-citationOlive Oil Consumption and Cardiovascular Protection: Mechanism of Action
Chrysant, S. G., & Chrysant, G. S. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000449 · Cited by 14
“5,55,56”
Crosstalk Between Cholesterol, ABC Transporters, and PIP2 in Inflammation and Atherosclerosis
Gulshan, K. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-21547-6_13 · Cited by 12
Nanogels with covalently bound and releasable trehalose for autophagy stimulation in atherosclerosis
Zhong, Y., Maruf, A., Qu, K., Milewska, M., Wandzik, I., Mou, N., Cao, Y., & Wu, W. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02248-9 · Cited by 14
“Trehalose has also been proved to be an effective autophagy inducer in atherosclerosis, which drives macrophage autophagy-lysosomal biogenesis [20–23], thus it is beneficial for a long-term treatment to diminish the accumulated lipids in the plaques.”
BackgroundInhibition of CD36 ameliorates mouse spinal cord injury by accelerating microglial lipophagy
Wang, B., Du, A., Chen, X.-H., Huang, T., al Mamun, A., Li, P., Du, S.-T., Feng, Y.-Z., Jiang, L.-Y., Xu, J., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01463-w · Cited by 13
“Current evidence also indicates that the activation of lipophagy inhibits in fl ammation and ameliorates demyelination by lowering lipid loads in foam macrophages [20, 28].”
Li, S., Gao, G., Wu, F., Liu, D., Zhao, H., Ke, J., Liu, Y., Li, F., Li, J., Chen, Z., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28043 · Cited by 13
The Oncogene Transcription Factor EB Regulates Vascular Functions
Doronzo, G., Astanina, E., & Bussolino, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.640061 · Cited by 14
Короленко, Т. А., Johnston, T. P., & Větvička, V. (2020) · Molecules · doi:10.3390/molecules25215052 · Cited by 17
“TFEB has been shown to increase lysosomal lipid catabolism and lipolysis by regulating lysosomal biogenesis [33].”
BackgroundInfluentialZhao, S., Guo, H., Qiu, L., Zhong, C., Xue, J., Qin, M., Zhang, Y., Xu, C., Xie, Y., & Yu, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-61209-w · Cited by 16
“SAMB exhibits remarkable biological properties among these compounds and holds great The initiation, progression, and regression of atherosclerotic lesions are influenced by macrophages 36 .”
BackgroundAutophagy and Its Association with Macrophages in Clonal Hematopoiesis Leading to Atherosclerosis
Li, S., Zhou, X., Duan, Q., Niu, S., Li, P., Feng, Y., Zhang, Y., Xu, X., Gong, S., & Cao, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073252 · Cited by 11
“Disruption of these pathways in macrophages, particularly through deficiencies in key autophagy-related proteins, can exacerbate lipid accumulation and atherosclerotic plaque formation [120,136].”
The multifaceted role of autophagy and mitophagy in cardiovascular health and disease
Nàger, M., Calvoli, M., Larsen, K. B., & Birgisdottir, Å. B. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2572511 · Cited by 14
“In atheroprone ( apoe −/− ) mice, overexpression of TFEB results in decreased plaque formation, while the effect is abolished in mice with impaired macrophage autophagy through ATG5 or SQSTM1/p62 deficiency [183] .”
InfluentialWei, B., Lu, F., Kong, Q., Huang, Y., Huang, K., & Wu, W. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106208 · Cited by 12
Wang, B., Dong, G., Zhang, Q., Yan, F., Li, Z.-H., Li, C., Zhang, H., Ma, Q., Dai, J., Si, C., et al. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8317 · Cited by 14
“Basal autophagy maintains cellular lipid homeostasis (6-9) and the induction of autophagy has been observed to prevent AS (10-13).”
BackgroundMyeloid atg5 deletion impairs n-3 PUFA-mediated atheroprotection
Wang, Z., Sequeira, R. C., Zabalawi, M., Madenspacher, J. H., Boudyguina, E. Y., Ou, T., Nelson, J. M., Nie, Y., Zhao, Q., Fessler, M. B., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.01.004 · Cited by 12
“Moreover, intraperitoneal administration of trehalose (a natural sugar) as an inducer of macrophage autophagylysosomal biogenesis, caused atherosclerosis regression in apoE−/− mice without affecting plasma cholesterol (10).”
BackgroundMetabolic Regulators of Vascular Inflammation
Fairman, G., Robichaud, S., & Ouimet, M. I. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312582 · Cited by 12
Wen, T., Xie, J., Ma, L., Hao, Z., Zhang, W., Wu, T., & Li, L. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.11.016 · Cited by 10
Lycopene Regulates Macrophage Immune Response through the Autophagy Pathway Mediated by RIPK1
Yao, Y., Liu, X., Niu, X., Li, Y., & Han, L. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c02531 · Cited by 12
LRPPRC inhibits autophagy and promotes foam cell formation in atherosclerosis
Xu, Z., Li, X., Ding, Z., Zhang, Y., Peng, Z., Yang, X., Cao, W., & Du, R. (2022) · FEBS Journal · doi:10.1111/febs.16567 · Cited by 10
Morales-Carrizales, D. A., Gopar‐Cuevas, Y., Loera‐Arias, M. D. J., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., García‐García, A., & Rodríguez‐Rocha, H. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00468-w · Cited by 11
“Trehalose protective effects mediated by autophagy have been demonstrated in a wide variety of models, showing atheroprotective activity [11], improving chronic ischemic remodeling after myocardial infarction and decreasing hypertrophy, apoptosis, and fibrosis in the heart [12–15], and protecting…”
BackgroundSarad, K., Stefańska, M., Kraszewska, I., Szade, K., Sluimer, J. C., Błyszczuk, P., Dulak, J., & Jaźwa, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1249379 · Cited by 14
Ganjali, S., Jamialahmadi, T., Abbasifard, M., Emami, S. A., Tayarani‐Najaran, Z., Butler, A. E., Banach, M., & Sahebkar, A. (2022) · Archives of Medical Science · doi:10.5114/aoms/154987 · Cited by 9
“The positive anti-oxidant and anti-inflammatory effects of trehalose have been shown in 92 cellular and preclinical studies, suggesting the therapeutic capacity of this natural disaccharide against 93 a variety of diseases (13-22).”
BackgroundXu, W., Hu, Z., Tang, Y., Zhang, J., Xu, S., & Niu, Q. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03511-0 · Cited by 11
MondoA and AKI and AKI-to-CKD Transition
Maeda, S., Sakai, S., Takabatake, Y., Yamamoto, T., Minami, S., Nakamura, J., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Yonishi, H., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000414 · Cited by 9
“21,22 MondoA knockdown in Rubicon -de fi cient proximal tubular epithelial cells was conducted as described previously using MISSION short hairpin RNA Lentiviral Transduction Particles (Sigma-Aldrich, Saint Louis, MO, TRCN0000124922) with puromycin (Wisent, QC, Canada, 450-162-XL) selection.”
Self-citationIskandar, A. R., Kolli, A. R., Giralt, A., Neau, L., Fatarova, M., Kondylis, A., Torres, L. O., Majeed, S., Merg, C., Corciulo, M., et al. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112577 · Cited by 10
A bibliometric analysis of autophagy in atherosclerosis from 2012 to 2021
Zhang, F., Wang, R., Liu, B., & Zhang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977870 · Cited by 13
“, 2018) and metabolism in the body, especially in metabolic diseases such as atherosclerosis (Razani et al., 2012; Sergin et al., 2017), diabetes (Gonzalez et al.”
BackgroundMa, H., Ou, Z., Alaeiilkhchi, N., Cheng, Y., Chen, K., Chen, J., Guo, R.-Q., He, M.-Y., Tang, S.-Y., Zhang, X., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02185-y · Cited by 15
“Conversely, enhancing macrophage autophagy and lysosomal biogenesis can reduce atherosclerosis [41].”
BackgroundSelf-citationTrehalose Ameliorates Nonalcoholic Fatty Liver Disease by Regulating IRE1α–TFEB Signaling Pathway
Su, S., Liu, X., Zhu, M., Liu, W., Liu, J., Yuan, Y., Fu, F., Rao, Z., Liu, J., Lu, Y., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c08669 · Cited by 9
Sun, X.-J., Xiao, S., Ma, W., Jin, H. L., Ren, L., Yao, Y., Chen, Z.-D., Li, X., Chen, T., & Liu, N. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2023 · Cited by 8
Peng, G., Wei, L.-T., Jing, Y., Luo, H.-L., Liu, Z.-L., Wei, R.-C., Ning, J., Chang, G., & Wang, M. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156456 · Cited by 9
Zhang, H., Zhang, K., Liang, J., Yan, W., Wu, F., Xu, W.-M., Wu, Z., Chen, Y., Pan, R., & Wu, G. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13113 · Cited by 9
“Cellular autophagy is also involved in various CVDs including atherosclerosis,([17]) myocardial ischaemia–reperfusion injury,([18]) heart failure([19]) and cardiac hypertrophy.”
BackgroundAlves, L. S., Marques, A. R. A., Padrão, N., Carvalho, F. A., Ramalho, J. S., Lopes, C. S., Soares, M. I. L., Futter, C. E., Melo, T. M. V. D. P. E., Santos, N. C., et al. (2021) · Journal of Cell Science · doi:10.1242/jcs.254631 · Cited by 7
Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification
Ishiwata, R., & Morimoto, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166323 · Cited by 8
Micro/nanomotors in targeted drug delivery: Advances, challenges, and future directions
Ma, H., Li, R.-F., & Yu, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125471 · Cited by 7
Yeh, Y., Evans, T. D., Jeong, S., Liu, Z., Ajam, A., Cosme, C., Huang, J., Peroumal, D., Zhang, X., Javaheri, A., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1580684 · Cited by 8
“We previously demonstrated that the combination of oral and intraperitoneal (i.p.) administration of trehalose is atheroprotective in mice fed a western diet (40% high-fat diet, HFD) (26).”
InfluentialSelf-citationLysosomes and lysosomal dysfunction in ageing biology
Steinhauser, M. L., Liu, Y., Rizzo, S. J. S., Chen, B. B., Finkel, T., & Tan, J. X. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02007-6 · Cited by 10
“The natural disaccharide trehalose, a well-known activator of autophagy, potently activates TFEB and is associated with benefit in several preclinical disease models 146,147 .”
Li, R., Chen, L., Yao, B., Rahimnejad, S., Ren, J., Luo, Y., Qiao, F., Zhang, M., & Du, Z. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.738600 · Cited by 8
Kul, E., & Stork, O. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2261682 · Cited by 7
“Importantly, rescue of pathologies through trehalose-mediated autophagic induction has been shown even in systems with initially overwhelmed and dysfunctional autophagy (Sergin et al. 2017).”
BackgroundMacrophage ontogeny and functional diversity in cardiometabolic diseases
Gautier, E. L., Askia, H., Murcy, F., & Yvan‐Charvet, L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.023 · Cited by 9
TFEB – at the crossroads of host–pathogen interactions
Keerti, K., Pant, A., & Manjithaya, R. R. (2021) · Journal of Cell Science · doi:10.1242/jcs.252981 · Cited by 9
Wang, R., Chan, S. Y., & Finkel, T. (2026) · Circulation · doi:10.1161/circulationaha.125.075567 · Cited by 11
Nakamura, J., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Minami, S., Sakai, S., Yonishi, H., Maeda, S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.184451 · Cited by 11
“These results reveal a presumptive mechanism for the pathogenesis of APOA4 amyloidosis and suggest that TFEB activators, including trehalose (35, 89), may be a therapeutic strategy for CKD-related metabolic disorders and age-related APOA4 amyloidosis.”
Self-citationSwiprosin-1 deficiency in macrophages alleviated atherogenesis
Tong, L., Wang, Z.-B., Zhang, J., Wang, Y., Liu, W., Yin, H., Li, J., Su, D., Cao, Y., Zhang, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00739-y · Cited by 6
Zhou, J., Liu, L., Wu, P., Жао, Л., & Wu, Y. (2022) · BMC Genomics · doi:10.1186/s12864-022-09052-z · Cited by 6
“MITF regulate lysosomal biogenesis and function, and lysosomal dysfunction in macrophages has been reported as a risk of atherosclerosis development [49].”
BackgroundAnimal models and lysosomal pathogenesis of atherosclerosis
Wang, Z., Li, X., Moura, A. K., Hu, J. Z., Wang, Y., & Zhang, Y. (2025) · Animal Advances · doi:10.48130/animadv-0025-0003 · Cited by 5
Induction of TFEB promotes Kupffer cell survival and reduces lipid accumulation in MASLD
Chan, M. M., Daemen, S., Beatty, W. L., Byrnes, K., Cho, K., Ferguson, D., Feldstein, N., Park, C., Guo, Z., Park, A. C., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000853 · Cited by 7
“[23,24] Genetic overexpression and pharmacological activation of TFEB in macrophages have been shown to (1) rescue lipid-induced lysosome dysfunction in atherosclerosis and (2) protect against obesity via growth differentiation factor 15 (GDF15) expression.”
Self-citationFomin, M., Zapf, K., Schieffer, E., Freitag, J., Bange, G., & Schieffer, B. (2026) · Inflammation Research · doi:10.1007/s00011-026-02283-w · Cited by 6
“Through associated processes like insulin resistance, atherosclerosis and MASLD/MASH, a self-reinforcing loop of lipid overload, impaired autophagy and chronic inflam - mation is established [73, 140, 141].”
Wang, Y., Liao, Q., Mei, X., Han, X., Luo, L., Huang, R., Tang, Y., & Zhou, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326687 · Cited by 8
“Enhancing autophagic activity in macrophages facilitates intracellular lipid degradation; while inhibition of autophagy pre-disposes cells to necrosis and inflammation following foam cell death, contributing to plaque formation and rupture [25].”
InfluentialRole of Swiprosin-1/EFHD2 as a biomarker in the development of chronic diseases
Puttalingaiah, R. T. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120462 · Cited by 5
Jiang, B., Xuan, L. I., Mo, W. A. N. G., Guang-Xin, L. I., Ren, P., Yu-Qi, W. A. N. G., Xin, S.-J., & Qin, L. (2023) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2023.03.002 · Cited by 7
Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model
Cataldo, V. D., Debatisse, J., Agudelo, J. P., Géloën, A., Grandin, C., Verset, M., Taborik, F., Labaronne, E., Loizon, E., Millon, A., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab064 · Cited by 8
A Novel PHOX/CD38/MCOLN1/TFEB Axis Important For Macrophage Activation During Bacterial PhagocytosisPreprint
Najibi, M., Moreau, J. A., Honwad, H. H., & Irazoqui, J. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/669325 · Cited by 5
Amino Acid Metabolism and Autophagy in Atherosclerotic Cardiovascular Disease
Wu, Y., Avcilar-Kücükgöze, I., Santovito, D., & Atzler, D. (2024) · Biomolecules · doi:10.3390/biom14121557 · Cited by 7
“Studies have demonstrated that macrophage autophagic dysfunction occurs in both murine and human atherosclerotic lesions, which are mainly characterized by the accumulation of autophagosomes and impaired autophagic flux, and defective fusion of autophagosomes with lysosomes [42,43].”
Targeting CFTR restoring aggrephagy to suppress HSC activation and alleviate liver fibrosis
Zhang, L., Huang, W., Ma, T., Shi, X. D., Chen, J., Hu, Y., Liu, Y., Liu, Z., & Lu, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113754 · Cited by 4
Zhang, Y., He, H., Sawuer, G., Ma, X.-K., Ainiwaer, Z., Wu, D., Zhang, X., & Dong-qing, A. (2025) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-01004-z · Cited by 5
“Lipophagy, acting as a self-protective cellular mechanism, is critical for promoting lipid phagocytosis and cholesterol efflux (Sergin et al .”
Self-citationMaruf, A., Gerasymchuk, D., Hlushchuk, I., Er, Ş., Milewska, M., Chmielarz, P., Domanskyi, A., Airavaara, M., & Wandzik, I. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02704c · Cited by 6
Honwad, H. H., Najibi, M., Shen, J., Watts, S., Fu, A., Koscsó, B., Bogunovic, M., & Irazoqui, J. E. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf077 · Cited by 6
TFEB Gene Promoter Variants Effect on Gene Expression in Acute Myocardial Infarction
Zhang, J., Zhang, Y., He, X., Wang, S., Pang, S., & Yan, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630279 · Cited by 4
Aufiero, M. A., Shlezinger, N., Gjonbalaj, M., Mills, K. A. M., Ballabio, A., & Hohl, T. M. (2023) · Infection and Immunity · doi:10.1128/iai.00217-23 · Cited by 5
“While overexpression of TFEB was found to increase lysosome biogenesis in murine macrophages (37), we did not observe significant differences in LysoTracker staining between TFEB and TFE3 knockout cells and wild-type cells, suggesting functional redundancy in lysosomal biogenesis and acidification…”
BackgroundSelf-citationZandi, R., Razani, H. O., Mehrvar, A., Jowshan, M.-R., Sahebkar, A., Nikooyeh, B., Zahedi, H., & Talebi, S. (2024) · Trials · doi:10.1186/s13063-024-08667-9 · Cited by 4
The effect of trehalose on intracellular and extracellular nucleotide metabolism. A pilot study
Opiełka, M., Sobocki, B. K., Mierzejewska, P., & Smolenski, R. T. (2020) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2020.1772492 · Cited by 4
Rizehbandi, M., Dadfar, E., Nami, M. R., Nami, M. R., & Nami, M. (2026) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2026.100181 · Cited by 4
Schirone, L., Vecchio, D., Valenti, V., Picchio, V., Schiavon, S., D’Ambrosio, L., Nonno, F. D., Miglietta, S., Relucenti, M., Madaro, L., et al. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01174-9 · Cited by 3
“TRE activates the transcription factor TFEB, a critical promoter of autophagosomal and lysosomal biogenesis, whereas SP inhibits p300, an acetyltransferase and potent autophagy inhibitor [27, 37].”
Ganjali, S., Mansouri, A., Reiner, Ž., Jamialahmadi, T., Moallem, S. A., Salehabadi, S., Banach, M., & Sahebkar, A. (2023) · Archives of Medical Science · doi:10.5114/aoms/170159 · Cited by 3
“The promising anti97 atherogenic benefits of TRE have consistently been shown in various pro-atherogenic animal models (23, 25), 98 substantiating its potential for improving MI-induced complications in patients with MI.”
BackgroundWang, B., Chen, R., Yin, T., Li, Y., Xi, Z., Li, B., & Chu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146055 · Cited by 5
The role of autophagy in the pathogenesis and treatment of multiple sclerosis
Righes, G., Semenzato, L., Koutsikos, K., Zanato, V., Pinton, P., Giorgi, C., & Patergnani, S. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2529196 · Cited by 5
“Restoration of lipophagy through trehalose treatment, known to reduce lipid accumulation in atherosclerotic macrophages [90], results in decreased inflammation and a progressive reduction in the lipid load of foamy macrophages.”
Current treatment modalities for dry eye disease
Tatarnikova, E. B., & Кривошеина, О. И. (2021) · Russian Journal of Clinical Ophthalmology · doi:10.32364/2311-7729-2021-21-1-18-23 · Cited by 4
“Большое число научных исследований последних лет посвящено изучению влияния природного дисахарида трегалозы на организм человека, обладающей способностью вызывать аутофагию клеток [11, 12].”
Wada, S., Arimura, H., Nagayoshi, M., Sawa, R., Kubota, Y., Matoba, K., Hayashi, C., Shibuya, Y., Hatano, M., Takehana, Y., et al. (2022) · Advanced Biology · doi:10.1002/adbi.202101309 · Cited by 4
Lv, J., Wang, D., & Li, T. X. (2022) · BMC Genomic Data · doi:10.1186/s12863-022-01023-3 · Cited by 5
Yang, W., Su, G., & Liu, Y. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221110348 · Cited by 3
“However, studies have found that large amounts of oxidized low density lipoprotein (ox-LDL) in atherosclerotic plaques block autophagy, leading to p62 accumulation.(8,9) It remains to be seen whether the accumulation of the p62 protein affects macrophage polarization and worsens AS.”
BackgroundZhu, M., Jin, T., Wu, D., Zhang, S., & Wang, A. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s426155 · Cited by 3
Sakai, M., Ohnishi, K., Masuda, M., Harumoto, E., Fukuda, T., Ohnishi, A., Ishii, S., Ohminami, H., Yamanaka‐Okumura, H., Ohashi, K., et al. (2024) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.24-22 · Cited by 2
“(15) Genes related to endocytic receptors, caveolin, and clathrin adaptor are also regulated by TFEB, and TFEB overexpression promotes the uptake of extracellular molecules.”
BackgroundCzuba, M., Szafrańska, K., Kołaczkowski, M., & Marcinkowska, M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118951 · Cited by 2
Feng, Y., Wang, Q., He, B., & Hou, X. (2024) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000129 · Cited by 2
Pyruvate dehydrogenase alleviates macrophage autophagy in Hcy-induced ApoE–/– mice
Liu, Q., Feng, L., Hu, S., Ding, N., Ma, F., Hao, Y., Li, G., Xiong, J., Zhang, H., & Jiang, Y. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025021 · Cited by 2
“It also degrades cholesterol ingested by macrophages before it is effluxed, thereby preventing lipid accumulation and foam cell formation in atherosclerosis [6,7].”
Zhaorigetu, S., Prathipati, P., Rodriguez‐Aguayo, C., Walton, B. L., Sood, A. K., & Berestein-Lopez, G. (2019) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2019.77008 · Cited by 2
“Previous studies have demonstrated the role of autophagy in various pathological conditions and the association with apoptosis [6].”
BackgroundLi, M., Wang, J., Qian, Q., Chen, B., Zhang, Z., Barroso, E., Zhang, Y., Hall, D. D., Abel, E. D., Song, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.03.498477 · Cited by 3
Role of Autophagy in the Occurrence and Development of Atherosclerosis Induced by Low Shear Stress
王, 志. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12121632 · Cited by 1
Metadata
- Authors
- Sergin, I., Evans, T. D., Zhang, X., Bhattacharya, S., Stokes, C. J., Song, E., Ali, S., Dehestani, B., Holloway, K. B., Micevych, P. S., Javaheri, A., Crowley, J. R., Ballabio, A., Schilling, J. D., Epelman, S., Weihl, C. C., Diwan, A., Fan, D., Zayed, M. A., & Razani, B.
- Affiliations
- Washington University in St. Louis (US)
- Telethon Institute Of Genetics And Medicine (IT)
- University Health Network (CA)
- University of South Carolina (US)
- Corresponding author
- Razani, Babak
- ORCID
- Venue
- Nature Communications
- Published
- 2017-06-07
- Volume
- 8
- Issue
- 1
- Pages
- 15750-15750
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5467270
- OpenAlex
- W2622769153
- Cited by
- 351
- References
- 52
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 35 · 2023: 35 · 2022: 50 · 2021: 55 · 2020: 50 · 2019: 32 · 2018: 31 · 2017: 5
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (I01BX001969)
- Foundation for Barnes-Jewish Hospital
- National Heart, Lung, and Blood Institute (K08HL132060, R01HL116626, F31HL132434, K08HL098559, R01HL107594, T32HL007081, R01HL125838)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341, P30DK020579)
- National Center for Complementary and Integrative Health (P01AT003961)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- atherosclerosis, macrophages, TFEB, aggrephagy, trehalose, macrophage apoptosis, IL-1β, atherosclerotic plaque, autophagy dysfunction, atherosclerosis treatment
- MeSH terms
- Sequestosome-1 Protein, Animals, Autophagy, Humans, Lysosomes, Macrophages, Mice, Inbred C57BL, Mice, Transgenic, Microtubule-Associated Proteins, Trehalose, Mice, Knockout, Atherosclerosis, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.